Atreca
Atreca
Generate and develop cancer immunotherapeutics
Human health & social work | Global | Access to Information |
Profile Provided By: Company Website
Overview
Atreca is a biotechnology company that develops novel therapeutics through a deep understanding of the human immune response with a focus on innovative novel cancer immunotherapeutics. With its Immune Repertoire Capture (IRC) technology Atreca has an unparalleled insight into how cancer patients immune responses can drive better clinical outcomes. Atreca was founded by scientists industry experts and investors who share the vision that unlocking the immune response of today s patients is the key to creating a new generation of therapies.
Industry |
Legal Structure |
Operating Status |
Employees |
| Human health & social work | C Corporation | Operating | 11 - 50 employees |
Funding and Financing Rounds
2015 / $56M / Series A
Jun, 2012 / $6M / PRI / Cash & Convertible Note
Team
Impact
Geographies:
Social Objectives:
Environmental Objectives:
Operational Impact:
- Social Policies and Performance
Impact Reports & Metrics
Offices
Headquarters
500 Saginaw Drive, First Floor
Redwood City, California 94063
United States of America